OC-0163 Risk classification for PSA relapse after PSMAPET-guided RT for oligorecurrent prostate cancer. (April 2019) - Vogel, M.; Kroeze, S.G.C.; Henkenberens, C.; Schmidt-Hegemann, N.S.; Kirste, S.; Becker, J.; Christiansen, H.; Belka, C.; Grosu, A.L.; Müller, A.-C.; Guckenberger, M.; Combs, S.E.